Chief Accounting Officer · Tempus AI, Inc. · Class A Common Stock
Grant or award — administrative, little informational value
No reported dollar value · 44.3% of prior position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 10 | Epstein David RDirector | Open-market sale · 10b5-1 plan | SELL | $27K 370 sh | Nov 4, 2026 traded Nov 2, 2026 | |
| 0 | Fukushima RyanCEO, Data | Grant or award · 10b5-1 plan | A | — 100.0K sh | Nov 4, 2026 traded Nov 2, 2026 | |
| 3 | Fukushima RyanCEO, Data | Open-market sale · 10b5-1 plan | SELL | $5,943 80 sh | Nov 4, 2026 traded Nov 2, 2026 | |
| 23 | Schoenherr Thomas EdwardCEO, Diagnostics | Open-market sale · 10b5-1 plan | SELL | $874K 10.3K sh | Sep 29, 2026 traded Sep 25, 2026 | |
| 26 | Bartolucci Ryan MChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $530K 7,062 sh | Sep 18, 2026 traded Sep 17, 2026 | |
| 16 | Polovin AndrewEVP, Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $221K 2,951 sh | Sep 18, 2026 traded Sep 17, 2026 | |
| 13 | Fukushima RyanCEO, Data | Open-market sale · 10b5-1 plan | SELL | $49K 700 sh | Sep 18, 2026 traded Sep 16, 2026 | |
| 27 | Fukushima RyanCEO, Data | Open-market sale · 10b5-1 plan | SELL | $376K 5,900 sh | Sep 3, 2026 traded Sep 1, 2026 | |
| 27 | Fukushima RyanCEO, Data | Open-market sale · 10b5-1 plan | SELL | $683K 10.9K sh | Sep 3, 2026 traded Sep 1, 2026 | |
| 20 | Fukushima RyanCEO, Data | Open-market sale · 10b5-1 plan | SELL | $65K 1,000 sh | Sep 3, 2026 traded Sep 1, 2026 | |
| 27 | Fukushima RyanCEO, Data | Open-market sale · 10b5-1 plan | SELL | $810K 13.0K sh | Sep 3, 2026 traded Sep 1, 2026 | |
| 27 | West NadjaDirector | Open-market sale · 10b5-1 plan | SELL | $207K 3,000 sh | Sep 1, 2026 traded Aug 28, 2026 | |
| 30 | Fukushima RyanCEO, Data | Open-market sale · 10b5-1 plan | SELL | $1.00M 14.3K sh | Aug 25, 2026 traded Aug 21, 2026 | |
| 16 | Schoenherr Thomas EdwardCEO, Diagnostics | Open-market sale · 10b5-1 plan | SELL | $189K 2,694 sh | Aug 25, 2026 traded Aug 21, 2026 | |
| 46 | Bartolucci Ryan MChief Accounting Officer | Open-market sale | SELL | $306K 6,175 sh | Aug 20, 2026 traded Aug 18, 2026 | |
| 23 | Polovin AndrewEVP, Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $444K 7,927 sh | Aug 20, 2026 traded Aug 19, 2026 | |
| 26 | Polovin AndrewEVP, Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $1.10M 22.1K sh | Aug 20, 2026 traded Aug 18, 2026 | |
| 16 | Schoenherr Thomas EdwardCEO, Diagnostics | Open-market sale · 10b5-1 plan | SELL | $30K 494 sh | Aug 20, 2026 traded Aug 19, 2026 | |
| 19 | Schoenherr Thomas EdwardCEO, Diagnostics | Open-market sale · 10b5-1 plan | SELL | $54K 900 sh | Aug 20, 2026 traded Aug 19, 2026 | |
| 19 | Schoenherr Thomas EdwardCEO, Diagnostics | Open-market sale · 10b5-1 plan | SELL | $180K 2,994 sh | Aug 20, 2026 traded Aug 19, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Bartolucci Ryan M filed this Form 4 reporting a grant or award of TEM on May 4, 2026. It became public on May 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.